Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of inhaled nitric oxide on right ventricular function and pulmonary vascular mechanics following cardiac surgery
2022-003884-37Phase 3Active
- Sponsor
- Fernando Suarez Sipmann
- Start
- Feb 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nitric oxide in Postcardiac surgery state, Right heart dysfunction (RHF) and pulmonary hypertension (PH) (2 arms), sponsored by Fernando Suarez Sipmann. Primary endpoints: Parameters of right ventricular function, Pulmonary vascular mechanics and 1 more. Started Feb 2023; status: active.
02
Drugs
nitric oxide
03
Conditions
Postcardiac surgery stateRight heart dysfunction (RHF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2022-003884-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003884-37.